Balentine LLC’s Integra LifeSciences IART Stock Holding History

Balentine LLC’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-130	Closed	-$5K	–	510
2016 Q3	$5K	Sell	130 -130	-50%	-$5.45K	﹤0.01%	411
2016 Q2	$10K	Sell	260 -150	-37%	-$5.4K	﹤0.01%	345
2016 Q1	$14K	Hold	410	–	–	﹤0.01%	211
2015 Q4	$14K	Hold	410	–	–	﹤0.01%	283
2015 Q3	$12K	Sell	410 -92	-18%	-$2.88K	﹤0.01%	327
2015 Q2	$14K	Sell	502 -269	-35%	-$7.17K	﹤0.01%	290
2015 Q1	$19K	Buy	+771	New	+$18.2K	﹤0.01%	242

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Balentine LLC's IART Position: Q4 2016 in Review

Balentine LLC sold out of Integra LifeSciences (IART) in Q4 2016, closing a stake of 130 shares — an estimated $5K sold.

Balentine LLC first reported a position in IART in Q1 2015 and held it in 7 quarters. The position peaked at $19K in Q1 2015. 223 funds tracked by Wall St. Rank hold IART as of Q4 2016.

Balentine LLC reported no remaining Integra LifeSciences position as of Q4 2016 after selling out during the quarter.
Balentine LLC sold 130 Integra LifeSciences shares in Q4 2016, an estimated $5K.
Balentine LLC first reported a position in Integra LifeSciences in Q1 2015 and held it in 7 quarters.
Balentine LLC's Integra LifeSciences position peaked at $19K in Q1 2015.
223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2016.

Based on Balentine LLC's 13F filing for Q4 2016, filed 14 Feb 2017.